Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
Differences in parasite transmission intensity influence the process of acquisition of host immunity to Plasmodium falciparum malaria and ultimately, the rate of malaria related morbidity and mortality. Potentia...
Bright Adu, Mariama K. Cherif, Samuel Bosomprah, Amidou Diarra, Fareed K. N. Arthur, Emmanuel K. Dickson, Giampietro Corradin, David R. Cavanagh, Michael Theisen, Sodiomon B. Sirima, Issa Nebie and Daniel Dodoo
Malaria Journal 2016 15:123
Factors influencing adverse events reporting within the health care system: the case of artemisinin-based combination treatments in northern Ghana
The use of artemisinin-based combination therapy (ACT) as first-line treatment for uncomplicated malaria was a policy recommended by World Health Organization. In 2004, Ghana changed her first-line anti-malari...
Samuel Chatio, Raymond Aborigo, Philip Baba Adongo, Thomas Anyorigiya, Philip Ayizem Dalinjong, Patricia Akweongo and Abraham Oduro
Malaria Journal 2016 15:125
Anopheles subpictus carry human malaria parasites in an urban area of Western India and may facilitate perennial malaria transmission
India contributes 1.5–2 million annual confirmed cases of malaria. Since both parasites and vectors are evolving rapidly, updated information on parasite prevalence in mosquitoes is important for vector manage...
Ashwani Kumar, Rajeshwari Hosmani, Shivaji Jadhav, Trelita de Sousa, Ajeet Mohanty, Milind Naik, Adarsh Shettigar, Satyajit Kale, Neena Valecha, Laura Chery and Pradipsinh K. Rathod
Malaria Journal 2016 15:124
Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014–2017: an analysis of national allocations and regional grants
The Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM) has been the largest financial supporter of malaria since 2002. In 2011, the GFATM transitioned to a new funding model (NFM), which prioritizes ...
Brittany Zelman, Melissa Melgar, Erika Larson, Allison Phillips and Rima Shretta
Malaria Journal 2016 15:118
Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach
Countries of the greater Mekong subregion have made a transition from malaria control to an aim for falciparum and vivax malaria elimination. The elimination of falciparum malaria will have to be achieved agai...
Sara E. Canavati, Harriet L. S. Lawford, Bayo S. Fatunmbi, Dysoley Lek, Narann Top-Samphor, Rithea Leang, Arjen M. Dondorp, Rekol Huy and Walter M. Kazadi
Malaria Journal 2016 15:120
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
Combination therapy with artesunate plus sulfadoxine-pyrimethamine (SP) was adopted as recommended treatment for Plasmodium falciparum infection in Afghanistan in 2003.
Ghulam Rahim Awab, Mallika Imwong, Sasithon Pukrittayakamee, Fazel Alim, Warunee Hanpithakpong, Joel Tarning, Arjen M. Dondorp, Nicholas P. J. Day, Nicholas J. White and Charles J. Woodrow
Malaria Journal 2016 15:121
Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials
The US FDA recently developed CD3+, a counterfeit detection tool that is based on sample illumination at specific wavelengths of light and visual comparison of suspect sample and packaging materials to an auth...
JaCinta S. Batson, Daniel K. Bempong, Patrick H. Lukulay, Nicola Ranieri, R. Duane Satzger and Leigh Verbois
Malaria Journal 2016 15:119
Genotyping of Plasmodium vivax by minisatellite marker and its application in differentiating relapse and new infection
Plasmodium vivax malaria is a major public health problem in India. Control of vivax malaria is challenging due to various factors including relapse which increase the burden significa...
Ram Das, Ramesh C. Dhiman, Deepali Savargaonkar, Anupkumar R. Anvikar and Neena Valecha
Malaria Journal 2016 15:115
K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of ...
Aye A. Win, Mallika Imwong, Myat P. Kyaw, Charles J. Woodrow, Kesinee Chotivanich, Borimas Hanboonkunupakarn and Sasithon Pukrittayakamee
Malaria Journal 2016 15:110
Simultaneous quantification of artesunate and mefloquine in fixed-dose combination tablets by multivariate calibration with middle infrared spectroscopy and partial least squares regression
Malaria is one of the most lethal and life-threatening infectious diseases in the world, causing more than half a million deaths annually. Treatment with mefloquine and artesunate is currently recommended by t...
Breno Maurício Marson, Raquel de Oliveira Vilhena, Camilla Regina de Souza Madeira, Flávia Lada Degaut Pontes, Mário Sérgio Piantavini and Roberto Pontarolo
Malaria Journal 2016 15:109
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015)
The Malaria Policy Advisory Committee (MPAC) to the World Health Organization held its eighth meeting in Geneva, Switzerland from 16 to 18 September 2015. This article provides a summary of the discussions, co...
Malaria Journal 2016 15:117
Share with your friends: |